We are live on
!
Find out more
NPIC
Neumeier Poma Investment Counsel Portfolio holdings
AUM
$1.21B
1-Year Est. Return
70.48%
This Fund
S&P 500
This Quarter
Est. Return
+10.22%
1 Year Est. Return
+70.48%
3 Year Est. Return
+178.35%
5 Year Est. Return
+236.44%
10 Year Est. Return
+1,032.85%
AUM
$578M
AUM Growth
+$49.5M
(+9.4%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
2.38%
Top 10 Holdings %
Top 10 Hldgs %
41.46%
Holding
45
New
5
Increased
20
Reduced
12
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Supernus Pharmaceuticals
SUPN
|
+$13.9M |
| 2 |
Apogee Enterprises
APOG
|
+$13.8M |
| 3 |
BFX
BowFlex Inc.
BFX
|
+$11.7M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.31M |
| 5 |
Oxford Industries
OXM
|
+$9.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axos Financial
AX
|
+$13.8M |
| 2 |
AFSI
AmTrust Financial Services, Inc.
AFSI
|
+$6.81M |
| 3 |
NN Inc
NNBR
|
+$6.33M |
| 4 |
CORE
Core Mark Holding Co., Inc.
CORE
|
+$6.18M |
| 5 |
Badger Meter
BMI
|
+$5.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.16% |
| 2 | Consumer Discretionary | 23.75% |
| 3 | Financials | 14.45% |
| 4 | Industrials | 11.92% |
| 5 | Healthcare | 11.16% |
Similar funds
CS
AG
CCM
GC
DGM
SC
VC
FCCPG
Neumeier Poma Investment Counsel's Q4 2015 Portfolio in Review
As of Q4 2015, Neumeier Poma Investment Counsel held 45 positions worth $578M, up 9.4% from $529M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Neumeier Poma Investment Counsel's Q4 2015 filing shows 5 new, 20 increased, 12 reduced and 6 closed positions. Its largest new stake was Supernus Pharmaceuticals: 901,330 shares worth $12.1M. The largest sale was Axos Financial, an estimated $13.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Neumeier Poma Investment Counsel's largest Q4 2015 buy was Supernus Pharmaceuticals: 901,330 shares worth $12.1M.
- Neumeier Poma Investment Counsel added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015, an estimated $9.31M increase.
- Neumeier Poma Investment Counsel's biggest Q4 2015 reduction was AmTrust Financial Services, Inc., cutting an estimated $6.81M.
- Neumeier Poma Investment Counsel fully exited Axos Financial in Q4 2015, selling an estimated $13.8M.
- Neumeier Poma Investment Counsel's ten largest holdings make up 41% of its $578M portfolio in Q4 2015.
- Neumeier Poma Investment Counsel opened 5 new positions and closed 6 in Q4 2015.
- Neumeier Poma Investment Counsel's portfolio value rose 9.4% quarter-over-quarter to $578M.
Based on Neumeier Poma Investment Counsel's 13F filing for Q4 2015, filed 11 Feb 2016.